National and Kapodistrian University of Athens
Ακτινοθεραπεία στον καρκίνο μαστού σταδίου T1-2NO-1MO με επιταχυνόμενο σχήμα υποκερματισμού δόσης: έλεγχος ανταπόκρισης και εκτίμηση άμεσης και όψιμης τοξικότητας
Abstract
dc:descriptionIn the present study participated 54 patients (mean age 56 ± 9). 39 of 54 patients (72,2%), had tumors with volume between 0-1.9 cm and 15 of 54 patients (27,8%) had tumors with volume between 2-4,9 cm. 44 patients (81,5%), had positive lymph nodes and 10 (18,5%) had negative lymph nodes. By the end of the therapy it was observed that 36 patients (66,7%) had side effects grade 0, 13 patients (24,1%) had side effects grade 1 and 5 patients (9,3%) had side effects grade 2. One month after the end of the therapy it was observed that 42 patients (77,8%) had side effects grade 0, 7 patients (13,0%) had side effects grade 1, 4 patients (7,4%) had side effects grade 2 and 1 patient (1,9%) had side effects grade 3. Two months after the end of the therapy it was observed that 48 patients (88,9%) had side effects grade 0, 5 patients (9,3%) had side effects grade 1, 1 patient (1,9%) had side effects grade 2. Three months after the end of the therapy it was observed that 49 patients (90,7%) had side effects grade 0 and 5 patients (9,3%) had side effects grade 1. Six months after the end of the therapy it was observed that 49 patients (90,7%) had side effects grade 0 and 5 patients (9,3%) had side effects grade 1. Twelve months after the end of the therapy it was observed that 52 patients (96,3%) had side effects grade 0 and 2 patients (3,7%) had side effects grade 1. Eighteen months after the end of the therapy it was observed that 53 patients (98,1%) had side effects grade 0 and 1 patient (1,9%) had side effects grade 1. Twenty four months after the end of the therapy it was observed that all of the 54 patients (100,0%) had side effects grade 0. Kaplan-Meier analysis showed that 50% of the patients had no side effects by the end of the therapy (total relapse of breast to normal condition) and that 75% of the patients relapsed one month after the end of the therapy. Statistical analysis of the correlation between the kind of the therapy and the grade, revealed no significant results. Next mammography findings were evaluated. Six months after the end of the therapy it was observed that 6 patients (11,1%) had thickening of trabecula 0, 18 patients (33,3%) had thickening of trabecula 1, 20 patients (37,0%) had thickening of trabecula 2 and 10 patients (18,5%) had thickening of trabecula 3. Twelve months after the end of the therapy it was observed that 22 patients (40,7%) had thickening of trabecula 0, 21 patients (38,9%) had thickening of trabecula 1 and 11 patients (20,4%) had thickening of trabecula 2. Twenty four months after the end of the therapy it was observed that 47 patients (87,0%) had thickening of trabecula 0 and 7 patients (13%) had βαθμό επίτασης δοκίδωσης 1. Patients distribution according to skin thickening was the following: Six months after the end of the therapy it was observed that 8 patients (14,8%) had grade 0, 23 patients (42,6%) had grade 1, 17 patients (31,5%) had grade 2 and 6 patients (11,1%) had grade 3. Twelve months after the end of the therapy it was observed that 26 patients (48,1%) had grade 0, 21 patients (38,9%) had grade 1, 6 patients (11,1%) had grade 2 and 1 patient (1,9%) had grade 3. Twenty four months after the end of the therapy it was observed that 43 patients (79,6%) had grade 0, 10 patients (18,5%) had grade 1 and 1 patient (1,9%) had grade 2. ..........................................................
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zygogianni, Anna
- Ζυγογιάννη, Άννα
Subjects
dc:subject × 18- Ακτινοθεραπεία μαστού
- Καρκίνος μαστού
- Επιταχυνόμενο σχήμα
- Υποκερματισμός δόσης
- Οξείες δερματικές αντιδράσεις
- Απώτερες δερματικές αντιδράσεις
- Κοσμητικά αποτελέσματα
- Radiotherapy
- Breast cancer
- Accelerated irradiation
- Hypofractionated irradiation
- Acute effect
- Late effect
- Cosmetic results
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23405